| Population pharmacokinetics of teicoplanin and its dosing recommendations for neutropenic patients with augmented renal clearance for hematological malignancies K Sako, Y Nakamaru, K Ikawa, T Maeda, S Goto, Y Ishihara, Y Kato, ... Therapeutic Drug Monitoring 43 (4), 519-526, 2021 | 9 | 2021 |
| Application of machine learning techniques in population pharmacokinetics/pharmacodynamics modeling M Uno, Y Nakamaru, F Yamashita Drug Metabolism and Pharmacokinetics, 101004, 2024 | 3 | 2024 |
| Effect of infusion time on risk of Bacillus cereus bloodstream infections in patients administered with BFLUID amino acid infusions via peripheral venous catheters A Takano, Y Nakamaru, KI Sako, A Takano, M Iga, M Machida, T Kaku, ... Biomedical Reports 22 (2), 17, 2024 | | 2024 |
| Renin‑angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab T Chiba, H Ujiie, Y Yaegashi, K Umehara, S Takada, K Otaki, KI Sako, ... Biomedical Reports 17 (3), 1-8, 2022 | | 2022 |
